問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
柯宗佑
下載
2025-03-01 - 2030-06-30
Condition/Disease
The time elapsed before the first occurrence of any of the following events: • Hospitalization due to HF • Non-hospitalized HF • Death due to CV
Test Drug
Baxdrostat Dapagliflozin
Participate Sites18Sites
Recruiting18Sites
2024-09-01 - 2028-12-31
Participate Sites16Sites
Recruiting16Sites
2026-06-01 - 2030-06-30
Participate Sites14Sites
Recruiting14Sites
2023-10-02 - 2030-09-30
Participate Sites10Sites
Recruiting10Sites
2024-05-01 - 2029-12-31
2023-07-01 - 2026-01-31
Participate Sites7Sites
Recruiting7Sites
2024-06-01 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
2023-06-20 - 2026-06-30
2023-03-01 - 2027-02-28
Participate Sites17Sites
Recruiting17Sites
2025-08-01 - 2031-03-31
Participate Sites8Sites
Recruiting8Sites
全部
